STOCK TITAN
  1. Home
  2. Sec-filings
  3. SBRA
  4. [Form 4] Sabra Health Care REIT, Inc. Insider Trading Activity

Director Malehorn gets 8,310 stock units at Sabra Health Care REIT (SBRA)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Malehorn Jeffrey A. reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT director Jeffrey A. Malehorn received an equity grant of 8,310 restricted stock units of common stock as compensation. The award was granted under Sabra’s 2009 Performance Incentive Plan and carries no purchase price.

The units vest in equal monthly installments beginning on July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting. After this grant, Malehorn has beneficial ownership of 116,346 shares/units, including 8,310 unvested stock units and 55,016 stock units that have vested but with payment deferred, each unit representing one share of common stock.

Positive

  • None.

Negative

  • None.

Insights

Director received routine stock unit grant that increases equity-based compensation but does not involve open-market buying or selling.

Director Jeffrey A. Malehorn was granted 8,310 restricted stock units of Sabra Health Care REIT, Inc. common stock as an award under the 2009 Performance Incentive Plan. The grant carries a per-share price of $0.00, confirming it as compensation rather than a market purchase.

The units vest in equal monthly installments from July 17, 2026 through the earlier of June 17, 2027 or the day before the next annual stockholders’ meeting, creating a time-based retention incentive. Following the grant, Malehorn beneficially owns 116,346 shares and units in total, which frames the grant as a modest but meaningful addition to his existing position.

Insider Malehorn Jeffrey A.
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 8,310 $0.00 --
Holdings After Transaction: Common Stock — 116,346 shares (Direct)
Footnotes (1)
  1. Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the date of the next annual stockholders' meeting. Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.
Restricted stock units granted 8,310 units Grant of common stock units to director on June 17, 2026
Grant price per share $0.00 per unit Equity award under 2009 Performance Incentive Plan
Total holdings after grant 116,346 shares/units Director’s beneficial ownership following the transaction
Unvested stock units 8,310 units Unvested portion of director’s stock units
Vested but deferred units 55,016 units Vested units with payment deferred to a later date
Vesting start date July 17, 2026 First monthly vesting date for new grant
Vesting end date June 17, 2027 Latest possible monthly vesting date, subject to earlier meeting
restricted stock units financial
"Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2009 Performance Incentive Plan financial
"Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan."
deferred financial
"55,016 stock units that have vested but the payment of which has been deferred."
annual stockholders' meeting financial
"ending on the earlier of June 17, 2027 or the day before the date of the next annual stockholders' meeting."

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →

FAQ

What did Sabra Health Care REIT (SBRA) director Jeffrey A. Malehorn receive in this Form 4 filing?
Jeffrey A. Malehorn received an award of 8,310 restricted stock units of Sabra common stock. The grant is compensation under the 2009 Performance Incentive Plan and does not involve any cash paid by Malehorn to acquire the shares.

How do the 8,310 restricted stock units for SBRA’s director vest over time?
The 8,310 restricted stock units vest in equal monthly installments. Vesting starts on July 17, 2026 and continues until the earlier of June 17, 2027 or the day before Sabra’s next annual stockholders’ meeting, creating a roughly one-year vesting window.

How many Sabra Health Care REIT (SBRA) shares and units does Jeffrey A. Malehorn own after this grant?
After the grant, Jeffrey A. Malehorn beneficially owns 116,346 shares and units of Sabra common stock. This total includes 8,310 unvested stock units and 55,016 vested units with deferred payment, each unit representing the right to receive one share.

Is the 8,310-unit award to SBRA’s director an open-market stock purchase?
No, the 8,310-unit award is not an open-market purchase. It is a grant of restricted stock units at a stated price of $0.00 per share, made under Sabra’s 2009 Performance Incentive Plan as part of the director’s equity compensation package.

What does it mean that 55,016 SBRA stock units are vested but payment is deferred?
The 55,016 vested but deferred Sabra stock units have already met vesting conditions, so they are earned. However, delivery of the underlying shares is postponed until a later payment date, reflecting the director’s deferral election or plan rules.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Malehorn Jeffrey A.
(Last)(First)(Middle)
C/O SABRA HEALTH CARE REIT, INC.
1781 FLIGHT WAY
(Street)
TUSTIN CALIFORNIA 92782
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/17/2026A8,310(1)A$0116,346(2)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the date of the next annual stockholders' meeting.
2. Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.
Remarks:
Exhibit List: Exhibit 24 - Power of Attorney
/s/ Michael Costa, as Attorney-in-Fact06/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR